Rozebalamin(R) for Injection 25 mg (Mecobalamin) Approved in Japan for Amyotrophic Lateral Sclerosis
TOKYO, Sept 24, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has obtained manufacturing and marketing authorization approval for amyotrophic lateral sclerosis (ALS) treatment ...
TOKYO, Nov 20, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the amyotrophic lateral sclerosis (ALS) treatment "Rozebalamin for Injection25 mg" (mecobalamin) has been launched in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback